Table 2.
Sample size | Treatment group | EPG at D0 mean ± SD | EPG at D14 mean ± SD | Reduction in % | LCL | UCL | Remark |
---|---|---|---|---|---|---|---|
15 | Ivermectin | 260 ± 54.11 | 6.67 ± 25.82a | 97.25 | 78.59 | 99.65 | Suspect |
15 | Fenbendazole | 223 ± 59.36 | 50 ± 65.46b | 79.4 | 66.50 | 89.96 | Resistance |
15 | Control | 200 ± 53.45 | 243 ± 84.23c | NA | NA | NA |
SD: standard deviation, NA: not applicable, D0: day 0, and D014: day 14. a, b, cStatistically different at P < 0.05.